SPAG9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.347200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.307400E-01
Normal-vs-Stage2
9.651600E-01
Normal-vs-Stage3
7.699500E-02
Normal-vs-Stage4
3.430800E-01
Stage1-vs-Stage2
6.015200E-01
Stage1-vs-Stage3
1.813040E-01
Stage1-vs-Stage4
8.870300E-02
Stage2-vs-Stage3
2.078000E-01
Stage2-vs-Stage4
2.401400E-01
Stage3-vs-Stage4
2.963800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.988000E-01
Normal-vs-AfricanAmerican
5.856200E-01
Normal-vs-Asian
2.427400E-01
Caucasian-vs-AfricanAmerican
3.899800E-01
Caucasian-vs-Asian
1.397450E-01
AfricanAmerican-vs-Asian
1.986210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.718600E-01
Normal-vs-Female
9.755000E-01
Male-vs-Female
4.615200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.502000E-01
Normal-vs-Age(41-60Yrs)
5.819400E-01
Normal-vs-Age(61-80Yrs)
6.904400E-01
Normal-vs-Age(81-100Yrs)
2.233000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.360800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.957400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.069600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.438430E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.028500E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.599200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.094600E-01
Normal-vs-Daily Drinker
1.929400E-01
Normal-vs-Weekly Drinker
6.413200E-01
Normal-vs-Occasional Drinker
6.962000E-01
Normal-vs-Social Drinker
6.061800E-01
Non Drinker-vs-Daily Drinker
6.770400E-01
Non Drinker-vs-Weekly Drinker
4.021200E-01
Non Drinker-vs-Occasional Drinker
2.286400E-02
Non Drinker-vs-Social Drinker
5.445700E-02
Daily Drinker-vs-Weekly Drinker
2.460200E-01
Daily Drinker-vs-Occasional Drinker
1.256200E-02
Daily Drinker-vs-Social Drinker
3.990400E-02
Weekly Drinker-vs-Occasional Drinker
1.660630E-01
Weekly Drinker-vs-Social Drinker
1.352960E-01
Occasional Drinker-vs-Social Drinker
5.516200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.060200E-01
Normal-vs-Grade 2
4.269600E-02
Normal-vs-Grade 3
2.355600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.778400E-01
Grade 1-vs-Grade 3
9.458400E-01
Grade 1-vs-Grade 4
2.060200E-01
Grade 2-vs-Grade 3
8.618400E-01
Grade 2-vs-Grade 4
4.269600E-02
Grade 3-vs-Grade 4
2.355600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.535800E-01
Normal-vs-NonDiabetic
8.316000E-01
Diabetic-vs-NonDiabetic
7.793000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.728600E-01
Normal-vs-NoPancreatitis
8.276400E-01
Pancreatitis-vs-NoPancreatitis
6.994200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.729000E-01
Normal-vs-N1
9.706400E-01
N0-vs-N1
6.661000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.903000E-01
Normal-vs-TP53-NonMutant
8.549200E-01
TP53-Mutant-vs-TP53-NonMutant
5.716400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
